Buprenorphine and pregnancy.
D002047:Buprenorphine / Q000009:adverse effects* / Q000627:therapeutic use; D000013:Congenital Abnormalities / Q000209:etiology*; D005260:Female; D005602:France; D006801:Humans; D007231:Infant, Newborn; D008691:Methadone / Q000009:adverse effects / Q000627:therapeutic use; D009357:Neonatal Abstinence Syndrome / Q000209:etiology*; D007752:Obstetric Labor, Premature / Q000139:chemically induced*; D009293:Opioid-Related Disorders / Q000188:drug therapy*; D011247:Pregnancy; D011256:Pregnancy Outcome; D047928:Premature Birth / Q000139:chemically induced*; D011446:Prospective Studies
D002047:Buprenorphine; D008691:Methadone